Kura Oncology, Inc. (KURA) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Kura Oncology, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.660 Good day, everyone. My name is Layla, and I will be your conference operator today. 00:00:03.660 -- 00:00:08.571 At this time, I would like to welcome you to the Cura Oncology first quarter 2026 financial 00:00:08.571 -- 00:00:13.744 results earnings call. All lines have been placed on mute to prevent any background noise. 00:00:13.744 -- 00:00:16.687 After the speaker's remarks, there will be a question and answer session. 00:00:16.687 -- 00:00:19.732 If you would like to ask a question during this time, and if you have joined via the 00:00:19.732 -- 00:00:23.639 webinar, please use the raise hand icon, which can be found at the bottom of your webinar 00:00:23.639 -- 00:00:28.326 application. To allow everyone the opportunity to participate, we ask that you please 00:00:28.326 -- 00:00:32.714 limit yourself to one question and then re-enter the queue for any follow-ups. 00:00:32.714 -- 00:00:36.861 At this time, I would like to turn the call over to Greg Mann, SVP of Investor Relations 00:00:36.861 -- 00:00:40.514 and Corporate Affairs of Cura Oncology. Please go ahead. 00:00:40.514 -- 00:00:45.465 Thank you, Leila. Good afternoon and welcome to Cura Oncology's first quarter 2026 conference 00:00:45.465 -- 00:00:50.758 call. Joining the call today are Dr. Troy Wilson, President and Chief Executive Officer, 00:00:50.758 -- 00:00:53.324 Brian Powell, Chief Commercial Officer, Dr. 00:00:53.324 -- 00:00:58.275 Molly Leone, Chief Medical Officer, and Tom Doyle, Senior Vice President, Finance and 00:00:58.275 -- 00:01:02.869 Accounting. We remind you that today's discussion will include forward-looking statements 00:01:02.869 -- 00:01:07.634 based on current expectations. Such statements represent management's judgment as of 00:01:07.63...